Skip to content

The paradoxical psychological effects of lysergic acid diethylamide (LSD)

Robin Carhart-Harris, Mendel Kaelen, Mark Bolstridge, Tom A. Williams, Lindsey Williams, Raphael Underwood, Amanda Feilding, David Nutt

Psychological Medicine February 5, 2016 DOI: 10.1017/s0033291715002901 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Within-subjects controlled trial Peer reviewed
Sample size 20
Population Healthy volunteers
Intervention LSD
Dose 75 µg, intravenously
Duration 2-week follow-up after each session
Topics LSD Mescaline Psilocybin
Keywords Hallucinogen Mood Cognition Clinical psychology Psychosis Placebo
Citations 301
Key findings LSD acutely produced heightened mood and psychosis-like symptoms, yet two weeks later increased optimism and trait openness without changes in delusional thinking.

Abstract

Background: Lysergic acid diethylamide (LSD) is a potent serotonergic hallucinogen or psychedelic that modulates consciousness in a marked and novel way. This study sought to examine the acute and mid-term psychological effects of LSD in a controlled study.

Method: A total of 20 healthy volunteers participated in this within-subjects study. Participants received LSD (75 µ g, intravenously) on one occasion and placebo (saline, intravenously) on another, in a balanced order, with at least 2 weeks separating sessions. Acute subjective effects were measured using the Altered States of Consciousness questionnaire and the Psychotomimetic States Inventory (PSI). A measure of optimism (the Revised Life Orientation Test), the Revised NEO Personality Inventory, and the Peter's Delusions Inventory were issued at baseline and 2 weeks after each session.

Results: LSD produced robust psychological effects; including heightened mood but also high scores on the PSI, an index of psychosis-like symptoms. Increased optimism and trait openness were observed 2 weeks after LSD (and not placebo) and there were no changes in delusional thinking.

Conclusions: The present findings reinforce the view that psychedelics elicit psychosis-like symptoms acutely yet improve psychological wellbeing in the mid to long term. It is proposed that acute alterations in mood are secondary to a more fundamental modulation in the quality of cognition, and that increased cognitive flexibility subsequent to serotonin 2A receptor (5-HT 2A R) stimulation promotes emotional lability during intoxication and leaves a residue of ‘loosened cognition’ in the mid to long term that is conducive to improved psychological wellbeing.

Comparable studies

Other non-randomized and open-label trials on LSD, most cited first.

Study Year Design Participants
Study of Lysergic Acid Diethylamide as an Analgesic Agent Hospital patients 1964 Clinical trial n = 50
Localization of serotonin 5‐HT2 receptors in living human brain by positron emission tomography using N1‐([11C]‐methyl)‐2‐BR‐LSD Normal human volunteers 1987 Clinical trial n = 7
Psychedelic Therapy Utilizing LSD in the Treatment of the Alcoholic Patient: A Preliminary Report Alcoholic patients 1967 Pilot study n = 69
LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study Patients with LSD-induced hallucinogen persisting perception disorder (HPPD) 2000 Open-label pilot study n = 8
DOET(2,5-Dimethoxy-4-Ethylamphetamine), a New Psychotropic Drug Normal male subjects 1971 Controlled trial

Citations in the library

Explore topics